Inactive Instrument

SCP & CO Healthcare Acquisition Company Share Price

Equities

SHAC

US7840651043

Investment Holding Companies

Dynamic Chart
SCPCO Appoints Karim Hijazi as Managing Director and General Partner CI
SCP&CO Appoints Chris Rivera as President CI
SCP & CO Healthcare Acquisition Company(NasdaqCM:SHAC) dropped from NASDAQ Composite Index CI
SCP & CO Healthcare Acquisition Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
SCP & CO Healthcare Acquisition Company Announces Resignation of Randy Parker as Director CI
SCP & CO Healthcare Acquisition Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
SCP & CO Healthcare Acquisition Company Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
SCP & CO Healthcare Acquisition Company Reports Earnings Results for the Full Year Ended December 31, 2021 CI
SCP & CO Healthcare Acquisition Company Auditor Raises 'Going Concern' Doubt CI
SCP & CO Healthcare Acquisition Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
SCP & CO Healthcare Acquisition Company Appoints Mohit Kaushal to the Board CI
Scp & Co Healthcare Acquisition Company Reports Earnings Results for the Second Quarter Ended June 30, 2021 CI
Certain Class B Common Stock of SCP & CO Healthcare Acquisition Company are subject to a Lock-Up Agreement Ending on 21-JUL-2021. CI
Scp & Co Healthcare Acquisition Company Reports Earnings Results for the First Quarter Ended March 31, 2021 CI
SCP & CO Healthcare Acquisition Company(NasdaqCM:SHAC) added to NASDAQ Composite Index CI
More news
Managers TitleAgeSince
Chief Executive Officer - 30/09/02
Director of Finance/CFO 55 -
President 54 20/06/23
Members of the board TitleAgeSince
Director/Board Member 63 20/01/21
Director/Board Member 66 30/09/20
Director/Board Member 66 20/01/21
More insiders
SCP & CO Healthcare Acquisition Company is a blank check company. The Company's business purpose is to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The Company focuses on businesses in the healthcare technology or healthcare-related industries in the United States and other developed countries. The Company has no operations and has not generated revenues.
More about the company